Rodman David Malcom
Chief Medical Officer at MLYS; Exec Vice President and CMO at ALPINE IMMUNE SCIENCES, INC.
- Sold, on record
- $20.1M
- Dollars the filings state
- Form 4 sales
- 37
- Latest Aug 10, 2026
- Form 144 notices
- 9
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- MLYSMineralys Therapeutics, Inc.Chief Medical Officer
- ALPINE IMMUNE SCIENCES, INC.Exec Vice President and CMO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- MLYS828,074 shares
- ALPINE IMMUNE SCIENCES, INC.18,457 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MLYSRoutineMay 13, 2026 2026
Sold 22,575 shares at $28.91 ($653k)
Rodman David Malcom, Chief Medical Officer
10b5-1 planSold 26.2% of holdings ($2.5M position)63,443 shares left2x usual sizeFiling
- 2 Form 4 sale MLYSRoutineMay 18, 2026 +5 days
Sold 417 shares at $27.55 ($11k)
Rodman David Malcom, Chief Medical Officer
10b5-1 planSold 0.7% of holdings ($1.8M position)63,443 shares left0x usual sizeFiling
- 3 Form 4 sale MLYSRoutineJun 12, 2026 +25 days
Sold 8,519 shares at $24.20 ($206k)
Rodman David Malcom, Chief Medical Officer
10b5-1 planSold 11.8% of holdings ($1.7M position)63,443 shares left0.7x usual sizeFiling
- 4 Form 4 sale MLYSRoutineJun 17, 2026 +5 days
Sold 14,474 shares at $24.19 ($350k)
Rodman David Malcom, Chief Medical Officer
10b5-1 planSold 20.2% of holdings ($1.7M position)57,095 shares left1.3x usual sizeFiling
- 5 Form 4 sale MLYSRoutineJul 9, 2026 +22 days
Sold 2,171 shares at $30.30 ($66k)
Rodman David Malcom, Chief Medical Officer
10b5-1 planSold 3.6% of holdings ($1.8M position)57,733 shares left0.2x usual sizeFiling
- 6 Form 4 sale MLYSRoutineJul 15, 2026 +6 days
Sold 20,407 shares at $27.28 ($557k)
Rodman David Malcom, Chief Medical Officer
10b5-1 planSold 28.4% of holdings ($2M position)51,384 shares left1.8x usual sizeFiling
- 7 Form 4 sale MLYSRoutineJul 17, 2026 +2 days
Sold 416 shares at $26.53 ($11k)
Rodman David Malcom, Chief Medical Officer
10b5-1 planSold 0.8% of holdings ($1.4M position)51,384 shares left0x usual sizeFiling
- 8 Form 4 sale MLYSRoutineAug 10, 2026 +24 days
Sold 2,170 shares at $27.09 ($59k)
Rodman David Malcom, Chief Medical Officer
10b5-1 planSold 4.1% of holdings ($1.5M position)51,384 shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (46)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Aug 12, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 2,170 | $59k | 4.1% | Routine | SEC |
| Jul 17, 2026 | Jul 20, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 416 | $11k | 0.8% | Routine | SEC |
| Jul 15, 2026 | Jul 15, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 20,407 | $557k | 28.4% | Routine | SEC |
| Jul 9, 2026 | Jul 10, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 2,171 | $66k | 3.6% | Routine | SEC |
| Jun 17, 2026 | Jun 17, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 14,474 | $350k | 20.2% | Routine | SEC |
| Jun 12, 2026 | Jun 12, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 8,519 | $206k | 11.8% | Routine | SEC |
| May 18, 2026 | May 19, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 417 | $11k | 0.7% | Routine | SEC |
| May 13, 2026 | May 13, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 22,575 | $653k | 26.2% | Routine | SEC |
| Apr 17, 2026 | Apr 21, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 416 | $13k | 0.6% | Routine | SEC |
| Apr 15, 2026 | Apr 15, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 20,406 | $549k | 22.6% | Routine | SEC |
| Apr 9, 2026 | Apr 13, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 2,170 | $59k | 2.8% | Routine | SEC |
| Mar 17, 2026 | Mar 17, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 417 | $11k | 0.5% | Routine | SEC |
| Mar 13, 2026 | Mar 16, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 20,406 | $543k | 21.1% | Routine | SEC |
| Mar 9, 2026 | Mar 10, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 2,171 | $58k | 2.6% | Routine | SEC |
| Feb 17, 2026 | Feb 17, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 417 | $12k | 0.9% | Routine | SEC |
| Feb 13, 2026 | Feb 13, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 20,404 | $570k | 31.6% | Routine | SEC |
| Feb 9, 2026 | Feb 11, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 2,171 | $66k | 4.1% | Routine | SEC |
| Jan 20, 2026 | Jan 20, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 416 | $13k | 0.8% | Routine | SEC |
| Jan 14, 2026 | Jan 15, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 19,076 | $623k | 27.4% | Routine | SEC |
| Jan 12, 2026 | Jan 13, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 8,518 | $277k | 12.1% | Routine | SEC |
| Jan 5, 2026 | Jan 6, 2026 | MLYS | Chief Medical Officer | Form 4 sale | 262,752 | $9.3M | 81.0% | Unusual | SEC |
| Oct 15, 2025 | Oct 15, 2025 | MLYS | Chief Medical Officer | Form 4 sale | 10,369 | $446k | 12.7% | Routine | SEC |
| Sep 15, 2025 | Sep 16, 2025 | MLYS | Chief Medical Officer | Form 4 sale | 11,367 | $409k | 12.2% | Routine | SEC |
| Aug 13, 2025 | Aug 14, 2025 | MLYS | Chief Medical Officer | Form 4 sale | 11,365 | $147k | 10.9% | Routine | SEC |
| Jul 14, 2025 | Jul 15, 2025 | MLYS | Chief Medical Officer | Form 4 sale | 11,366 | $166k | 10.4% | Routine | SEC |
| Jun 13, 2025 | Jun 16, 2025 | MLYS | Chief Medical Officer | Form 4 sale | 11,366 | $166k | 10.1% | Routine | SEC |
| May 14, 2025 | May 15, 2025 | MLYS | Chief Medical Officer | Form 4 sale | 11,366 | $174k | 9.6% | Routine | SEC |
| May 14, 2025 | May 14, 2025 | MLYS | Officer | Form 144 notice | 11,366 | $174k | Notice | SEC | |
| Apr 14, 2025 | Apr 15, 2025 | MLYS | Chief Medical Officer | Form 4 sale | 11,366 | $165k | 9.2% | Routine | SEC |
| Apr 14, 2025 | Apr 14, 2025 | MLYS | Officer | Form 144 notice | 11,366 | $165k | Notice | SEC | |
| Apr 1, 2025 | Apr 3, 2025 | MLYS | Chief Medical Officer | Form 4 sale | 55,771 | $879k | 32.3% | Unusual | SEC |
| Apr 1, 2025 | Apr 1, 2025 | MLYS | Officer | Form 144 notice | 55,771 | $879k | Notice | SEC | |
| Nov 11, 2024 | Nov 12, 2024 | MLYS | Chief Medical Officer | Form 4 sale | 5,026 | $75k | 3.4% | Routine | SEC |
| Nov 11, 2024 | Nov 12, 2024 | MLYS | Officer | Form 144 notice | 5,026 | $75k | Notice | SEC | |
| Nov 6, 2024 | Nov 8, 2024 | MLYS | Chief Medical Officer | Form 4 sale | 25,482 | $383k | 15.8% | Unusual | SEC |
| Nov 6, 2024 | Nov 6, 2024 | MLYS | Officer | Form 144 notice | 25,482 | $383k | Notice | SEC | |
| Jul 16, 2024 | Jul 18, 2024 | MLYS | Chief Medical Officer | Form 4 sale | 525 | $8k | 0.5% | Routine | SEC |
| Jul 16, 2024 | Jul 16, 2024 | MLYS | Officer | Form 144 notice | 525 | $8k | Notice | SEC | |
| May 9, 2024 | May 10, 2024 | MLYS | Chief Medical Officer | Form 4 sale | 100 | $2k | 0.1% | Routine | SEC |
| May 9, 2024 | May 9, 2024 | MLYS | Officer | Form 144 notice | 100 | $2k | Notice | SEC | |
| Aug 11, 2023 | Aug 11, 2023 | MLYS | Chief Medical Officer | Form 4 sale | 231,716 | $3M | 100.0% | Unusual | SEC |
| Aug 11, 2023 | Aug 11, 2023 | MLYS | Officer | Form 144 notice | 5,018 | $64k | Notice | SEC | |
| Aug 10, 2023 | Aug 10, 2023 | MLYS | Officer | Form 144 notice | 226,698 | $3M | Notice | SEC | |
| Jan 4, 2017 | Jan 5, 2017 | ALPINE IMMUNE SCIENCES, INC. | Exec Vice President and CMO | Form 4 sale | 6,687 | $15k | 37.0% | Unusual | SEC |
| Oct 4, 2016 | Oct 5, 2016 | ALPINE IMMUNE SCIENCES, INC. | Exec Vice President and CMO | Form 4 sale | 5,820 | $46k | 32.2% | Unusual | SEC |
| Jul 5, 2016 | Jul 6, 2016 | ALPINE IMMUNE SCIENCES, INC. | Exec Vice President and CMO | Form 4 sale | 5,950 | $28k | 33.0% | Unusual | SEC |